Israël Demain #54 – Zebra, une application qui va révolutionner le monde de la radiologie

« Zebra aide les radiologistes à gérer leur charge de travail, sans cesse croissante, sans compromettre la qualité. » David Chettrit de la start up Zebra nous parle d’une application qui va révolutionner le monde de la radiologie. Israël demain, c’est l’émission des innovations sur Studio Qualita présentée par Olivier Granilic.
A écouter sur :
Zebra’s mission is to provide radiologists the tools they need to make the next leap in patient care. The demand for medical imaging services is continuously increasing, outpacing the supply of qualified radiologists and stretching them to produce more output, without compromising patient care. Only by adopting new technology that significantly enhances the capabilities of radiologists, can this crisis be mitigated. Zebra is empowering radiologists with its revolutionary AI1 offering which helps health providers manage the ever increasing workload without compromising quality.
Zebra-Med’s patents address statistical and machine learning methods to assess the risk, as well as the existence of osteoporotic fractures, by means of classifying and correlating various bone density scores, emulating DEXA scores, and analyzing bone structure. The latest patent, which was received in February 2019, focuses on the volumetric analysis of bone mineral density values extracted from CT studies.
Zebra-Med’s two previous patents, received in August and October of 2018, focus on the ability to estimate DEXA scores from a representative portion of CT studies of the lumbar area of the spine. The additional patent focuses on the volumetric analysis of CT studies to produce and estimate DEXA scores.
“These patents and others in the pipeline emphasize our commitment to the bone health sector and to further innovation that will improve patients’ lives, » said Eyal Gura, Zebra-Med Co-Founder and CEO. “We are proud to demonstrate AI’s real impact on patients’ lives at the upcoming Osteoporosis Global Conference.”
Partager :